Prior authorization is a review the plan runs before it agrees to pay. The prescriber files a request, a reviewer at the local Blue Cross licensee or its benefit manager measures it against a written criteria document, and an answer comes back inside a set window. Approval is time-limited, tied to a specific dose, and has to be renewed.
What the review is and is not
Preauthorization is a decision that a service or drug is covered under a particular plan. It is not a clinical judgment about whether treatment is appropriate, and it is not permission to prescribe. A clinician can write the prescription whether or not the plan agrees to fund it. The review answers a narrower question, which is whether this member, under this plan document, meets rules the plan published in advance.
Those rules are not national. Blue Cross Blue Shield is a federation of independent, locally operated licensee companies, each maintaining its own drug list and its own criteria, and self-funded employer plans layer their own design on top. The reviewer is applying one specific rulebook, and the first practical task is finding out which rulebook that is.
Find the criteria document before anything is filed
Plans generally publish the criteria they apply to a given drug, and the member services line or the plan’s provider portal can produce it. Reading that document converts a vague process into a checklist. It names what has to be in the chart, what has to be tried first, what measurements are needed, and how long an approval runs.
The other document worth having in hand is the drug list, which tells you whether the product is on the list at all and on what tier. A drug that is not listed is a different conversation from a drug that is listed with an authorization requirement, and the two get confused constantly.
Patient-facing explainers can make that reading go faster. Providers such as HealthRX and Henry Meds publish plain summaries of how a plan handles this drug class, with HealthRX keeping a page on GLP-1 insurance coverage that lays out the authorization and step-therapy patterns most plans use, while national manufacturer channels like LillyDirect stay focused on their own products. None of that replaces the specific criteria document, but it sets expectations before the request is filed.
Who files it, and what actually moves
The prescribing office files the request, not the patient. What moves is a form plus supporting chart material: the diagnosis, relevant measurements, documented conditions occurring alongside the diagnosis, records of anything tried previously, and the exact drug, strength and quantity being requested. Patients help most by supplying what the office does not already hold, particularly records from previous practices and dated evidence of earlier medication trials.
Where the drug runs through a pharmacy benefit, the request usually goes to the pharmacy benefit manager. Where it runs through a medical benefit, it goes to the plan’s medical review team. The same drug can travel either path depending on how it is administered and how the plan is built, which is why two people describing the same process sometimes describe different offices.
Timelines and the urgent track
Standard requests are decided within a defined period after the plan receives the necessary information, and expedited review exists where waiting the standard period would seriously jeopardize health. The clock starts when the plan has what it asked for, not when the office first faxed something, which is the single most common reason a request appears to sit untouched. Ask for the date the plan logged the submission as complete.
Approval is a document with edges
An approval is written for a named drug, a named strength, a quantity per fill, and a period after which it lapses. Escalating the dose ahead of the approved schedule, or requesting a ninety-day fill against a thirty-day approval, produces a rejection that reads like lost coverage but is only a mismatch between the prescription and the approval on file.
Reauthorization is its own event. Continuation criteria typically ask for evidence that the drug is working and being tolerated, so weights, follow-up visit notes and adherence records taken during the first authorization period become the material the second request runs on. Building that record from the start costs nothing and saves a resubmission later.
| Stage | Who acts | What comes out of it | What to keep |
|---|---|---|---|
| Criteria lookup | Patient or prescribing office | The written rule set for this drug | A copy, with the version date |
| Submission | Prescribing office | Request logged by the plan | Date logged and a reference number |
| Review | Licensee or benefit manager | Approval, refusal or request for more information | The full determination letter |
| Dispensing | Pharmacy | Fill matching the approved terms | Strength, quantity and days supply |
| Reauthorization | Prescribing office | Continued or ended coverage | Weights, tolerability and visit notes |
Running a cost check while the review is pending
Reviews take time, and a decision can land either way, so a number of people price the alternative in parallel rather than waiting to find out. Manufacturer self-pay pharmacies operated by Eli Lilly and Novo Nordisk publish figures for brand-name products, and cash practices including Ro, Hims & Hers and LifeMD publish monthly program pricing. A posted monthly price and the provider behind it can be checked in minutes, which is worth doing before the pharmacy calls with an answer. Compounded preparations sold through some of those programs are not FDA-approved products, a distinction that belongs in the comparison alongside the price.
Questions people ask
Can a patient file the request themselves?
Generally no. Plans accept clinical requests from the prescribing office because the supporting material comes from the chart. Patients can and should chase the status, confirm the plan logged a complete submission, and supply outside records the office lacks, all of which shortens the process more than calling for updates does.
Does an approval guarantee the pharmacy will fill it?
Only if the prescription matches the approval. Approvals name a strength, quantity and duration, and many plans also designate which pharmacy may dispense this class of drug. A mismatch on any of those produces a rejection at the counter even though valid coverage exists on the plan’s side.
How long does an approval last?
It varies by plan and is stated in the determination letter, commonly running some months before continuation criteria apply. Diarizing the expiry date and starting the renewal ahead of it avoids a gap in supply, since the renewal is a fresh review rather than an automatic extension.
What if the plan asks for more information?
That is a pause, not a refusal, and it restarts the clock once the plan receives what it asked for. Getting the exact list of missing items in writing, rather than a paraphrase over the phone, is the difference between one resubmission and three.
